CERS.NASDAQCerus CORP

Form 4: Cerus Corp Insider Sells Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Cerus Corporation reports insider William Greenman sold 101,919 shares of common stock on June 30, 2026, as part of a pre-arranged trading plan.

Summary

  • William Greenman, President and CEO of Cerus Corporation, reported a transaction on June 30, 2026.
  • He acquired 192,500 shares of common stock at no cost.
  • He also disposed of 101,919 shares of common stock for a total of $299,619.01, at a weighted average price of $2.9429 per share.
  • These sales were executed under a Rule 10b5-1 trading plan to cover tax withholding obligations and brokerage fees related to the vesting of restricted stock units.
  • Following these transactions, Greenman beneficially owns 5,053,036 shares of common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the significant number of shares sold by a top executive, despite the explanation of a 10b5-1 plan for tax purposes.

Positives

  • The sale of shares was conducted under a Rule 10b5-1 plan, indicating pre-planned and potentially non-discretionary transactions.
  • The sale was intended to cover statutory tax withholding obligations and brokerage fees, suggesting a routine event rather than a distress sale.
  • William Greenman retains a significant beneficial ownership of 5,053,036 shares of common stock.

Negatives

  • An insider, the President and CEO, sold a substantial number of shares (101,919).

Risks

  • The sale of shares by a key executive could be perceived negatively by the market, potentially impacting investor confidence.
  • While the sale is attributed to a 10b5-1 plan for tax purposes, any significant insider selling can raise questions about the executive's outlook on the company's future performance.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on a specific insider transaction.

Management Comments

  • The sale of 101,919 shares was made pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
  • These shares were sold in multiple transactions at prices ranging from $2.84 to $3.03 per share, inclusive.
  • The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings, are closely watched by investors as they can signal management's confidence in the company's prospects. While this transaction is explained as a routine tax-related sale under a 10b5-1 plan, the volume of shares sold by a top executive warrants attention within the biotechnology and medical device sector where Cerus Corporation operates.

Stakeholder Impact

  • Shareholders: May interpret the sale as a signal of reduced confidence, potentially affecting share price, despite the stated reasons.
  • Employees: May observe the transaction as a reflection of executive sentiment towards the company's stock.
  • Management: The transaction is by a key executive, William Greenman, President and CEO.

Next Steps

  • The reporting person may provide further details on individual sale prices upon request from the Issuer, security holders, or the SEC staff.

Key Dates

DateDescription
06/30/2026Earliest transaction date, acquisition of 192,500 shares and disposition of 101,919 shares of common stock.
07/02/2026Date of signature for the filing.

Recommendation

hold

The filing reports an insider sale under a 10b5-1 plan for tax purposes, which is a common and often non-discretionary event. While significant, the explanation mitigates immediate concern. The company's overall performance and future prospects, not detailed in this specific filing, would be the primary drivers for a buy or sell recommendation. Therefore, a 'hold' is appropriate based solely on this transaction report.

Keywords

Cerus Corporation, CERS, Form 4, Insider Trading, William Greenman, Stock Sale, Rule 10b5-1, Beneficial Ownership, Restricted Stock Units, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.